Capecitabine: Have we got the dose right?
In the past 5-10 years there has been a growing trend for substituting conventional 5-fluorouracil with the oral prodrug of 5-fluorouracil, capecitabine, in chemotherapy regimens. This regimen change is based on evidence of the efficacy equivalence of these two drugs and the lack of an increase in o...
Main Authors: | Midgley, R, Kerr, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Capecitabine: have we got the dose right?
by: Midgley, R, et al.
Published: (2009) -
Capecitabine: Have we got the dose right?
by: Midgley, R, et al.
Published: (2009) -
Anti-TNF therapy: where have we got to in 2005?
by: Feldmann, M, et al.
Published: (2005) -
System identification of neural systems: If we got it right, would we know?
by: Han, Yena, et al.
Published: (2022) -
People with disabilities: An ancient society got it right, but can we?
by: Razak, Nor Izzati Ab, et al.
Published: (2018)